跳转至内容
Merck
CN
  • Development of optically controlled "living electrodes" with long-projecting axon tracts for a synaptic brain-machine interface.

Development of optically controlled "living electrodes" with long-projecting axon tracts for a synaptic brain-machine interface.

Science advances (2021-02-02)
Dayo O Adewole, Laura A Struzyna, Justin C Burrell, James P Harris, Ashley D Nemes, Dmitriy Petrov, Reuben H Kraft, H Isaac Chen, Mijail D Serruya, John A Wolf, D Kacy Cullen
摘要

For implantable neural interfaces, functional/clinical outcomes are challenged by limitations in specificity and stability of inorganic microelectrodes. A biological intermediary between microelectrical devices and the brain may improve specificity and longevity through (i) natural synaptic integration with deep neural circuitry, (ii) accessibility on the brain surface, and (iii) optogenetic manipulation for targeted, light-based readout/control. Accordingly, we have developed implantable "living electrodes," living cortical neurons, and axonal tracts protected within soft hydrogel cylinders, for optobiological monitoring/modulation of brain activity. Here, we demonstrate fabrication, rapid axonal outgrowth, reproducible cytoarchitecture, and simultaneous optical stimulation and recording of these tissue engineered constructs in vitro. We also present their transplantation, survival, integration, and optical recording in rat cortex as an in vivo proof of concept for this neural interface paradigm. The creation and characterization of these functional, optically controllable living electrodes are critical steps in developing a new class of optobiological tools for neural interfacing.

材料
货号
品牌
产品描述

Sigma-Aldrich
抗-β微管蛋白III (神经元)抗体,小鼠单克隆 小鼠抗, ~1.0 mg/mL, clone 2G10, purified from hybridoma cell culture
Sigma-Aldrich
聚二甲基硅氧烷, viscosity 1.0 cSt (25 °C)
Sigma-Aldrich
Aprotinin Nicotiana tobacco, >= 5TIU/mg protein, >= 98 % SDS-PAGE | 9087-70-1, recombinant, expressed in Nicotiana (tobacco), ≥5 TIU/mg protein, ≥98% (SDS-PAGE)